Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1347214rdf:typepubmed:Citationlld:pubmed
pubmed-article:1347214lifeskim:mentionsumls-concept:C0001554lld:lifeskim
pubmed-article:1347214lifeskim:mentionsumls-concept:C0035203lld:lifeskim
pubmed-article:1347214lifeskim:mentionsumls-concept:C0521451lld:lifeskim
pubmed-article:1347214lifeskim:mentionsumls-concept:C0011155lld:lifeskim
pubmed-article:1347214lifeskim:mentionsumls-concept:C0080356lld:lifeskim
pubmed-article:1347214lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:1347214lifeskim:mentionsumls-concept:C1524003lld:lifeskim
pubmed-article:1347214lifeskim:mentionsumls-concept:C0205191lld:lifeskim
pubmed-article:1347214lifeskim:mentionsumls-concept:C1412005lld:lifeskim
pubmed-article:1347214lifeskim:mentionsumls-concept:C0333668lld:lifeskim
pubmed-article:1347214pubmed:issue3lld:pubmed
pubmed-article:1347214pubmed:dateCreated1992-4-2lld:pubmed
pubmed-article:1347214pubmed:abstractTextLiver mitochondria from rats fed 1% (w/w) valproic acid for 75 days displayed an approximate 30% decrease in coupled respiration rates with substrates entering the respiratory chain at complexes I and II. Uncoupling the respiration from proton-pumping, or measuring the respiration without complex IV removed this inhibition. The treatment induced a loss of activity of cytochrome oxidase consistent with a decrease in the mitochondrial content of cytochrome aa3. The inhibition induced by long lasting administration of valproate is apparently located at the site of the proton-pumping activity of complex IV. Furthermore, the capacity of electron transport through complex IV, being far in excess of that required for normal functioning in coupled mitochondria, seems to be controlled by the coupling to proton-pumping in which cytochrome aa3 appears to play a major role.lld:pubmed
pubmed-article:1347214pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1347214pubmed:languageenglld:pubmed
pubmed-article:1347214pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1347214pubmed:citationSubsetIMlld:pubmed
pubmed-article:1347214pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1347214pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1347214pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1347214pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1347214pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1347214pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1347214pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1347214pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1347214pubmed:statusMEDLINElld:pubmed
pubmed-article:1347214pubmed:monthFeblld:pubmed
pubmed-article:1347214pubmed:issn0006-2952lld:pubmed
pubmed-article:1347214pubmed:authorpubmed-author:van HoofFFlld:pubmed
pubmed-article:1347214pubmed:authorpubmed-author:VeitchKKlld:pubmed
pubmed-article:1347214pubmed:authorpubmed-author:PonchautSSlld:pubmed
pubmed-article:1347214pubmed:issnTypePrintlld:pubmed
pubmed-article:1347214pubmed:day4lld:pubmed
pubmed-article:1347214pubmed:volume43lld:pubmed
pubmed-article:1347214pubmed:ownerNLMlld:pubmed
pubmed-article:1347214pubmed:authorsCompleteYlld:pubmed
pubmed-article:1347214pubmed:pagination644-7lld:pubmed
pubmed-article:1347214pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:1347214pubmed:meshHeadingpubmed-meshheading:1347214-...lld:pubmed
pubmed-article:1347214pubmed:meshHeadingpubmed-meshheading:1347214-...lld:pubmed
pubmed-article:1347214pubmed:meshHeadingpubmed-meshheading:1347214-...lld:pubmed
pubmed-article:1347214pubmed:meshHeadingpubmed-meshheading:1347214-...lld:pubmed
pubmed-article:1347214pubmed:meshHeadingpubmed-meshheading:1347214-...lld:pubmed
pubmed-article:1347214pubmed:meshHeadingpubmed-meshheading:1347214-...lld:pubmed
pubmed-article:1347214pubmed:meshHeadingpubmed-meshheading:1347214-...lld:pubmed
pubmed-article:1347214pubmed:meshHeadingpubmed-meshheading:1347214-...lld:pubmed
pubmed-article:1347214pubmed:meshHeadingpubmed-meshheading:1347214-...lld:pubmed
pubmed-article:1347214pubmed:meshHeadingpubmed-meshheading:1347214-...lld:pubmed
pubmed-article:1347214pubmed:meshHeadingpubmed-meshheading:1347214-...lld:pubmed
pubmed-article:1347214pubmed:meshHeadingpubmed-meshheading:1347214-...lld:pubmed
pubmed-article:1347214pubmed:meshHeadingpubmed-meshheading:1347214-...lld:pubmed
pubmed-article:1347214pubmed:meshHeadingpubmed-meshheading:1347214-...lld:pubmed
pubmed-article:1347214pubmed:meshHeadingpubmed-meshheading:1347214-...lld:pubmed
pubmed-article:1347214pubmed:meshHeadingpubmed-meshheading:1347214-...lld:pubmed
pubmed-article:1347214pubmed:year1992lld:pubmed
pubmed-article:1347214pubmed:articleTitleCytochrome aa3 depletion is the cause of the deficient mitochondrial respiration induced by chronic valproate administration.lld:pubmed
pubmed-article:1347214pubmed:affiliationLaboratory of Physiological Chemistry, Catholic University of Louvain.lld:pubmed
pubmed-article:1347214pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1347214pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:1347214pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1347214lld:pubmed